Sign inCreate account

Report workspace tools

NCT04893928UNKNOWNanonymous

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I)

Sponsor

Source record

Hospital Nacional Profesor Alejandro Posadas

Phase

Source record

registry-stage

Modality

AI-normalized

RNA therapy

Target

AI-normalized

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Indication / condition

AI-normalized

Inflammatory Bowel Diseases

Intervention

Source record

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Source & freshness

Source record

NCT ID

NCT04893928

Original source

ClinicalTrials.gov

Source last updated

May 21, 2021

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04893928

Title

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I)

Sponsor

Hospital Nacional Profesor Alejandro Posadas

Status

UNKNOWN

Phase

registry-stage

Condition raw

Inflammatory Bowel Diseases

Condition normalized

Inflammatory Bowel Diseases

Modality raw

MASH

Modality normalized

RNA therapy

Target raw

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Target normalized

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Interventions

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Public preview

Source record

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I) is a registry-stage clinical asset sponsored by Hospital Nacional Profesor Alejandro Posadas in Inflammatory Bowel Diseases, Knowledge, Attitudes, Practice, Quality of Life, Treatment Adherence and Compliance. SEO and diligence focus: QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I)

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04893928

Status

UNKNOWN

Phase

registry-stage

Sponsor

Hospital Nacional Profesor Alejandro Posadas

Executive brief

Investment-Ready Snapshot

Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial (Stage I) is a registry-stage clinical asset sponsored by Hospital Nacional Profesor Alejandro Posadas in Inflammatory Bowel Diseases, Knowledge, Attitudes, Practice, Quality of Life, Treatment Adherence and Compliance. SEO and diligence focus: QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMay 21, 2021
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04893928

Indication

Inflammatory Bowel Diseases

Modality

RNA therapy

Target

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Intervention

QUECOMIICAT survey, Self-Efficacy for Appropriate Medication Use Scale, ICTs preferences and barriers survey, Focus group and IBD mobile App for health support (MAHS) development and validation

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.